Table 1.
Demographics
| Controls (n = 11) | PD patients (n = 11) | p value | |
|---|---|---|---|
| Age, years | 62±11 | 61±9 | 0.65 |
| Male | 5 (46) | 8 (73) | 0.19 |
| Education, years | 16±3 | 17±2 | 0.6 |
| White | 10 (91) | 10 (91) | 1 |
| Disease duration, years | - | 13±4 | - |
| MDS-UPDRS-III OFF score | - | 49±8 | - |
| MDS-UPDRS-IIION score | - | 23±6 | - |
| Dyskinesia (OFF state) | - | 0 | - |
| Dyskinesia (ON state) | - | 10 (91) | - |
| Dyskinesia interfered with UPDRS ratings (ON state) | - | 2 (18) | - |
| LEDD, mg | 2,199±992; 1,200–3,920 | - |
Data are reported asn (%) or mean± SD; range. PD, Parkinson disease; MDS-UPDRS, Movement Disorder Society-Unified Parkinson's Disease Rating Scale; LEDD, levodopa equivalent daily dose.